How Wazoku has Solved Challenges in Cardiology

Solving Complex Cardiology Challenges with Wazoku’s Open Innovation Platform

At Wazoku, we harness the power of global collaboration through our Open Innovation Platform to solve complex challenges in cardiology and vascular health. By connecting experts worldwide, we’ve delivered innovative solutions for issues like leadless cardiac device implantation, AI-driven drug toxicity prediction, and precision medicine. Our work with organizations like AstraZeneca showcases how open innovation can drive breakthroughs in healthcare. Explore how Wazoku Crowd has transformed cardiology challenges and discover how you can leverage global expertise to solve your own.

Heart Implantation with Leadless Medical Devices

In this challenge, Wazoku’s Open Innovation platform was tasked with solving two major problems:

1. Precise Delivery: Ensuring the leadless device reaches its exact target in the heart.
2. Secure Fixation: Ensuring the device remains securely attached while allowing repositioning if needed.

With the heart’s complex internal structure and the delicate nature of the operation, the solution required a safe and effective way to deliver the device via a catheter and attach it to the ventricular wall without damaging surrounding tissues.

How Wazoku Crowd Solved It:

Wazoku’s global community of solvers proposed innovative approaches, including:

• New catheter designs to navigate the complex structure of the heart.
• Reversible attachment mechanisms for secure placement and repositioning of the device.
• Practical and cost-effective solutions using commercially available equipment.

These proposals provided detailed designs and operational insights, giving the Seeker the freedom to move forward with potential licensing agreements for future commercial applications.

Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Cardiology Innovation Challenge – Heart Disease and Stroke Treatment Decisions through Patient Insights

Heart disease and stroke often leave patients and their families facing difficult treatment decisions. To improve patient-centered care, the American Heart Association (AHA) and the Patient-Centered Outcomes Research Institute (PCORI) partnered with Wazoku to gather insights from those directly affected by cardiovascular disease (CVD) and stroke.

This challenge sought to understand the factors that influence patient decisions, such as:

• Length of life vs. quality of life: How patients prioritize these aspects in treatment decisions.
• Costs and convenience: How financial and logistical concerns impact treatment choices.
• Trust in information: Whether patients feel adequately informed and if the sources of information are reliable.

How Wazoku Crowd Made an Impact:

Through Wazoku’s platform, patients, caregivers, and families shared personal stories about the decisions they faced. This ideation challenge uncovered key insights about the challenges patients encounter when navigating their treatment options. The information gathered from these real-world experiences will guide future research and improve patient care by addressing what matters most to them.

Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Heart Disease and Stroke Treatment with Comparative Effectiveness Research and Precision Medicine

Building on previous insights from patients, AHA and PCORI turned to researchers and clinicians to develop new scientific questions around heart disease and stroke treatment. The goal was to integrate comparative effectiveness research (CER) and precision medicine into research questions that could guide future treatment approaches.

CER compares the benefits and harms of different treatment options to determine the most effective course for patients, while precision medicine tailors treatments to each patient’s unique characteristics.

How the Wazoku Crowd Delivered on this Cardiology Innovation Challenge:

Wazoku’s platform engaged experts in healthcare research, who refined patient-reported dilemmas into testable scientific questions. Their innovative proposals focused on:

• Comparing treatment options for conditions such as heart failure, stroke prevention, and congenital heart disease.
• Using precision medicine to customize treatment plans based on genetic, environmental, and lifestyle factors.

The research questions submitted will help shape future funding and research opportunities, ultimately improving the safety and efficacy of heart disease and stroke treatments.

Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Predicting Cardiac Pathology with AI and Computational Biology

Artificial intelligence (AI) and computational biology are transforming drug discovery, especially in predicting drug-induced cardiac pathology. AstraZeneca, through Wazoku’s Open Innovation platform, sought innovative approaches to improve the accuracy of predicting heart-related drug toxicity.

The challenge involved using AI, bioinformatics, and real-world data to develop models that predict drug-induced cardiac toxicity in rodent models.

How the Wazoku Crowd Solved It:

Wazoku’s global community of solvers proposed innovative solutions using:

• AI-driven models to analyze large datasets and identify patterns in drug-induced toxicity.
• Mechanistic hypotheses that explain how specific drugs cause cardiac issues, enhancing translational understanding.

These theoretical solutions provided AstraZeneca with novel approaches to test and refine, improving their ability to predict and prevent drug-related heart problems during the development phase.

Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Innovating Cardiac and Vascular Screening: A Pressure-Sensing Core for Microtissues

Cardiac and vascular spheroids—3D microtissues that simulate heart and blood vessel tissues—hold great promise for screening drug compounds. However, the Seeker needed a solution to monitor pressure at the core of these spheroids, a key factor in determining their physiological relevance.

How the Wazoku Crowd Solved the Cardiology Innovation Challenge:

Wazoku’s solvers proposed integrating micro-scale pressure sensors within the spheroids, allowing researchers to:

• Monitor real-time pressure changes to ensure they mimic real cardiovascular conditions.
• Detect drug-induced changes in pressure, providing an early indication of potential toxicity.

These proposals enhanced the accuracy of cardiac and vascular drug screening, helping to detect undesirable effects earlier in the drug discovery process.

Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Wazoku Open Innovation in Cardiology

Wazoku’s Open Innovation platform has proven to be a powerful tool for solving complex challenges. By bringing together a global community of solvers, Wazoku helps leading organizations in the Health and Life Sciences industry tackle their toughest problems, drive innovation, and improve patient outcomes.

Whether through cutting-edge technologies like AI, precision medicine, or patient-centered research, Wazoku Crowd continues to push the boundaries of what’s possible in healthcare innovation.

Interested in driving innovation for your organization?

Run your own challenge and unlock the power of global collaboration to solve your toughest problems.

Explore